Funding Alert Vol. 24 No. 1 Alert # 3 - January 22, 2013

Loading...

Texas Department of State Health Services icon Funding Information Center icon Toll free: 1-888-963-7111 ext. 7684 icon Austin phone: (512) 776-7684 icon Fax: (512) 776-7683


The Texas Department of State Health Services Funding Alert is published weekly.  If you wish to subscribe to the Funding Information Center Funding Alert and other services, please call (512) 776-7684 or fill out our online subscription form which can be found at: https://www.dshs.state.tx.us/fic/subscribe.aspx.  Information in the Funding Alert is not copyrighted and may be reproduced. The Texas Department of State Health Services Funding Information Center would appreciate credit for the material used and a copy of the reprint. For information on viewing Adobe Acrobat .pdf and other files, see file viewing information.

Disclaimer: External links to other sites are intended to be informational and do not have the endorsement of the Department of State Health Services. These sites may also not be accessible to persons with disabilities. External e-mail links are provided to you as a courtesy. Please be advised that you are not e-mailing the Texas Department of State Health Services (DSHS) and DSHS policies do not apply should you choose to correspond.


Funding News and Grant Tips

Flu Information for Persons with HIV/AIDS
With reports of flu widespread across Texas, state health officials are urging people to get a flu shot now and take other steps to protect themselves from the flu and its possible complications.
“Texas, like much of the country, saw an early start to the flu season and continues to experience a high level of flu and flu-like illness,” said DSHS Commissioner Dr. David Lakey. “The best thing people can do to protect themselves is to get a dose of flu vaccine now. There is plenty of vaccine available.”
People with HIV/AIDS are considered at increased risk from serious flu-related complications. Studies have shown an increased risk for heart- and lung-related hospitalizations in people infected with HIV during flu season as opposed to other times of the year, and a higher risk of flu-related death in HIV-infected people. Other studies have indicated that flu symptoms might be prolonged and the risk of flu-related complications is higher for certain HIV-infected people.
Vaccination with a flu shot has been shown to produce an immune response against influenza viruses in certain people infected with HIV. Because flu can result in serious illness, HIV-infected persons are recommended for vaccination. More information about influenza for people with HIV/AIDS can be found in the CDC Fact Sheet located at http://www.cdc.gov/flu/protect/hiv-flu.htm.
CDC researchers say this year’s flu vaccine is well matched with the strains now circulating. While the number of flu cases in Texas is high, DSHS has no indication that cases have been more severe than usual this season.
DSHS recommends vaccination for everyone six months old and older. It’s especially important for those in high-risk groups like children, people 65 and older, pregnant women and people with chronic health conditions such as HIV/AIDS.
Flu symptoms usually start abruptly and include fever, body aches, chills, a dry cough, sore throat, runny nose and extreme fatigue and can last a week or longer. There is an adequate supply of antiviral medications that can help lessen the severity and duration of the flu when started within 48 hours after symptoms appear.
“I encourage people who have a sudden onset of fever along with a cough or sore throat to talk to their doctor as soon as they can about possible treatment,” Lakey said.
In addition to getting vaccinated, people should remember to protect themselves and others from flu and other respiratory illnesses by washing their hands frequently, covering all coughs and sneezes and staying home if they’re sick.
There is more information on the flu, including a vaccine finder, at http://www.texasflu.org/. People can also contact their health care provider, local health department or dial 2-1-1 to find out where to get a flu shot.
From DSHS HIV/STD Program HIV-STD Insider e-mail, 1/16/13icon

DADS accepting nominations for 2013 Vision Awards
The Texas Department of Aging and Disability Services (DADS) is accepting nominations for its 2013 Vision Awards. The deadline to submit entries is 5 pm, Feb. 18, 2013.
The Vision Awards provide state-level recognition for exemplary service in three areas that support the agency's vision: wellness, dignity and choice. Annually, DADS presents two individual and one group award in each of the three categories.
Anyone can nominate an individual or group for an award. The person or group nominated does not have to be a DADS volunteer. Rather, their volunteer efforts should support the DADS vision that older Texans and people with disabilities be supported by a comprehensive and cost-effective service delivery system that promotes and enhances individual well-being, dignity and choice.
From Texas Department of Aging and Disability Services DADS General Bulletin e-mail, 1/14/12icon

Registration Now Open for Healthy Relationships Training
A training for the intervention Healthy Relationships is scheduled for March 12-15 in Austin. Healthy Relationships is a five-session, small-group intervention for men and women living with HIV/AIDS. It is based on Social Cognitive Theory and focuses on developing skills and building self-efficacy and positive expectations about new behaviors through modeling behaviors and practicing new skills. The training will be conducted by the Technology Transfer Team (3T) from the University of Texas Southwestern Medical Center.
To register, visit the Effective Interventions website at http://www.effectiveinterventions.org/includes/courselisting.cfm?SessionTypeID=15. Registration will be open until February 11.
To learn more, e-mail Mary Chapman McIntosh at mary.mcintosh@dshs.texas.gov or call her at (512) 533-3017.
From DSHS HIV/STD Program HIV-STD Insider e-mail, 1/16/13icon


Public Funding Opportunities

Behavioral & Integrative Treatment Development Program (R01): PA-13-077
SOURCE: National Institute on Drug Abuse (NIDA), National Institute on Alcohol Abuse and Alcoholism (NIAAA), Office of Behavioral and Social Sciences Research (OBSSR)
APPLICATION DEADLINE: 2/5, 6/5, 10/5. Expires 1/8/16.
$ AVAILABLE: The number of awards is contingent upon NIH appropriations, and the submission of a sufficient number of meritorious applications.
ELIGIBILITY: Public/state/private controlled institutions of higher education, nonprofits with and without 501(c)(3) IRS status (other than institutions of higher education), small businesses, for-profit organizations (other than small businesses), state governments, U.S. territories or possessions, Indian/Native American tribal government (federally recognized and other than federally recognized), Indian/Native American tribally designated organizations, non-domestic (non-U.S.) entities, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska native and native Hawaiian serving institutions, regional organizations, eligible agencies of the federal government, and faith-based or community-based organizations.
PURPOSE: The purpose of this announcement for R01 applications is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, optimize combinations, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities, in diverse settings; (2) drug abuse treatment and adherence interventions for use in primary care; (3) drug abuse treatment and adherence interventions that utilize technologies to boost effects and increase implementability; (4) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (5) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (6) interventions to treat chronic pain. Research of interest includes but is not limited to Stage II and Stage III efficacy research.
CFDA: 93.279, 93.273
CONTACT: Please see URL for multiple contacts. For more information see http://grants.nih.gov/grants/guide/pa-files/PA-13-077.html
From CDC National Prevention Information Network's (NPIN) Funding Database e-mail, 1/15/13icon
Subject(s) substance abuse research, medical research, HIV/AIDS prevention/education

Behavioral & Integrative Treatment Development Program (R03): PA-13-079
SOURCE: National Institute on Drug Abuse (NIDA), National Institute on Alcohol Abuse and Alcoholism (NIAAA), Office of Behavioral and Social Sciences Research (OBSSR)
APPLICATION DEADLINE: 2/16, 6/16, 10/16. Expires 1/8/16.
$ AVAILABLE: The number of awards is contingent upon NIH appropriations, and the submission of a sufficient number of meritorious applications.
ELIGIBILITY: Public/state/private controlled institutions of higher education, nonprofits with and without 501(c)(3) IRS status (other than institutions of higher education), small businesses, for-profit organizations (other than small businesses), state governments, U.S. territories or possessions, Indian/Native American tribal government (federally recognized and other than federally recognized), Indian/Native American tribally designated organizations, non-domestic (non-U.S.) entities, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska native and native Hawaiian serving institutions, regional organizations, eligible agencies of the federal government, and faith-based or community-based organizations.
PURPOSE: The purpose of this announcement for R03s is to encourage investigators to propose discrete well-defined projects that can be completed within two years. Projects of interest fall within the research domain of behavioral or integrated (e.g., behavioral and pharmacological) interventions targeting: (a) drug abuse (including comorbidities); (b) prevention of acquisition or transmission of HIV infection among individuals in drug abuse treatment; (c) promotion of adherence to drug abuse treatment, HIV and addiction medications; and (d) chronic pain. Specific examples include, but are not limited to studies focusing on: 1) Stage I intervention generation; 2) Stage I pilot or feasibility – and both should include the development of putative moderators, mediators, and change mechanisms; (3) Stage I studies to generate or refine drug abuse treatment or adherence interventions for use in primary care; (4) Stage I research to boost effects and increase implementability of interventions with creative use of technology or through other means.
CFDA: 93.279, 93.273
CONTACT: Please see URL for multiple contacts. For more information see http://grants.nih.gov/grants/guide/pa-files/PA-13-079.html
From CDC National Prevention Information Network's (NPIN) Funding Database e-mail, 1/15/13icon
Subject(s) substance abuse research, medical research, HIV/AIDS prevention/education, technology

Behavioral & Integrative Treatment Development Program (R34): PA-13-078
SOURCE: National Institute on Drug Abuse (NIDA), National Institute on Alcohol Abuse and Alcoholism (NIAAA), Office of Behavioral and Social Sciences Research (OBSSR)
APPLICATION DEADLINE: 2/16, 6/16, 10/16. Expires 1/8/16.
$ AVAILABLE: The number of awards is contingent upon NIH appropriations, and the submission of a sufficient number of meritorious applications.
ELIGIBILITY: Public/state/private controlled institutions of higher education, nonprofits with and without 501(c)(3) IRS status (other than institutions of higher education), small businesses, for-profit organizations (other than small businesses), state governments, U.S. territories or possessions, Indian/Native American tribal government (federally recognized and other than federally recognized), Indian/Native American tribally designated organizations, non-domestic (non-U.S.) entities, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska native and native Hawaiian serving institutions, regional organizations, eligible agencies of the federal government, and faith-based or community-based organizations.
PURPOSE: The purpose of this announcement for R34s is to encourage investigators to propose discrete well-defined projects that can be completed within three years. Projects of interest fall within the research domain of behavioral or integrated (e.g., behavioral and pharmacological) interventions targeting: (a) substance abuse (including comorbidities); (b) prevention of acquisition or transmission of HIV infection among individuals in substance abuse treatment; (c) promotion of adherence to substance abuse treatment, HIV and addiction medications; and (d) chronic pain. Specific examples include, but are not limited to studies focusing on: 1) Stage I intervention generation; 2) Stage I pilot or feasibility – and both should include the development of putative moderators, mediators, and change mechanisms. (3) Stage I studies to generate or refine substance abuse treatment or adherence interventions for use in primary care; (4) Stage I research to boost effects and increase implementability of interventions with creative use of technology.
CFDA: 93.279, 93.273
CONTACT: Please see URL for multiple contacts. For more information see http://grants.nih.gov/grants/guide/pa-files/PA-13-078.html
From CDC National Prevention Information Network's (NPIN) Funding Database e-mail, 1/15/13icon
Subject(s) substance abuse research, medical research, HIV/AIDS prevention/education


Private Funding Opportunities

2013 Innovator Awards Program for Transformative Inflammatory Bowel Disease Research Projects
SOURCE: Kenneth Rainin Foundation
APPLICATION DEADLINE: Letter of Intent: 2/15/13.
$ AVAILABLE: The Innovator Awards provide $100,000 for one year for proof of principle research. Innovator Award recipients who have demonstrated significant research progress are eligible for longer-term support through the KRF Breakthrough Awards Program. Innovator Awardees are evaluated for potential Breakthrough Awards at the end of their initial year of funding. One-page Letters of Intent, which must include the basic idea and the central experiment, will be accepted online at the KRF Web site from January 15 to February 15, 2013. Invited full applications will be due by May 1, 2013.
ELIGIBILITY: The program is open to tenure-track professors (or the equivalent) at all levels from any scientific discipline and from any nonprofit research institution worldwide. Interdisciplinary collaboration is strongly encouraged.
PURPOSE: As part of its mission to find a cure for ulcerative colitis and Crohn's disease, the Kenneth Rainin Foundation is inviting Letters of Intent for its 2013 Innovator Awards Program for Inflammatory Bowel Disease.
The program supports innovative "out-of-the-box" research projects that are potentially transformative to the foundation's efforts to diagnose, treat, and/or cure IBD. The program's key criteria for funding consideration include innovation, strong collaboration, scientific merit, and a high potential for success, as well as projects that, due to their innovative nature, may not be eligible for funding from the National Institutes of Health or other more traditional sources.
CONTACT: Please see URL for contact information. For more information see http://krfoundation.org/grants/health/
From The Foundation Center's Philanthropy News Digest RFP Bulletin e-mail, 1/11/13icon
Subject(s) medical research, health professions training

Advanced Endovascular Training Fellowship
SOURCE: Fogarty Institute for Innovation
APPLICATION DEADLINE: 2/15/13.
$ AVAILABLE: Between one and three fellowships will be awarded. In addition to providing a base salary of $75,000 and benefits of $15,000 to support the fellows' education and training, the Fogarty Institute will match each fellow with clinical advisors from different clinical disciplines, as well as an innovation and entrepreneurship advisor from the Fogarty Institute. During the fellowship, each fellow will be encouraged to conduct research in their area of interest and author publications based on their findings. The Fogarty Institute and its affiliated Taft Center for Clinical Research are located on the premises of El Camino Hospital in Mountain View, California.
ELIGIBILITY: Criteria for the fellowship include board-certified or -eligible training in interventional cardiology, interventional radiology, vascular surgery, or cardiovascular surgery. A California Physicians License will be required for program participants.
PURPOSE: Following the program's successful inaugural year, the Fogarty Institute for Innovation, a nonprofit organization that teaches physicians and engineers the skills and methodology necessary to translate their ideas into new patient therapies, has announced that it is accepting applications for its Advanced Endovascular Training Fellowship.
Slated to begin on July 8, 2013, the one-year experiential training program is designed to provide fellows with broad exposure to all aspects of endovascular patient care, with an emphasis on interventional training. Fellows also will have the opportunity to engage with the Fogarty Institute's early-stage medical device start-up companies and assist in the process of developing technologies to improve patient care.
CONTACT: Fogarty Institute for Innovation, Melchor Pavilion (at El Camino Hospital), 2490 Hospital Drive, Suite 310, Mountain View, CA 94040, e-mail: infofogarty@fogartyinstitute.org, (650) 962-4560. For more information see http://www.fogartyinstitute.org/fellowship.html
From The Foundation Center's Philanthropy News Digest RFP Bulletin e-mail, 1/11/13icon
Subject(s) medical research, health professions training, cardiovascular/heart disease

All about the Fruits and Veggies Grant Program
SOURCE: Jamba Juice
APPLICATION DEADLINE: 2/18/13.
$ AVAILABLE: The All About the Fruits and Veggies grant program will provide youth garden initiatives with $500 in gardening supplies, curriculum, soil amendments, and plants to help create engaging nutrition and gardening experiences.
ELIGIBILITY: The program is open to schools, community organizations, and nonprofit gardening programs with at least 15 children between the ages of 3 and 18. Schools must be located within a 50-mile radius of a Jamba Juice store.
PURPOSE: In celebration of the National Gardening Association's fortieth anniversary, Jamba Juice has announced that it will award grants to forty youth and school garden programs in the United States.
CONTACT: For questions, call (800) 538-7476.
From The Foundation Center's Philanthropy News Digest RFP Bulletin e-mail, 1/11/13icon
Subject(s) nutrition/food service, children's health, school health

Ms. Foundation Year-Long Fellowship
SOURCE: Ms. Foundation for Women
APPLICATION DEADLINE: 2/15/13.
$ AVAILABLE: The fellow will be a full-time paid employee of the Ms. Foundation for Women and will receive a generous benefits package.
ELIGIBILITY: Although the Ms. Foundation, which is located in Brooklyn, New York, prefers local applicants, it welcomes proposals based in other states.
PURPOSE: The Ms. Foundation for Women has announced that it is accepting proposals for its second annual fellowship, which will support a talented leader pursuing change related to the Ms. Foundation's advocacy and policy work.
Proposed approaches may include but are not limited to research and analysis, policy reports and white papers, technological innovation, state legislative strategy, and anti-discrimination initiatives. Examples of current Ms. Foundation policy initiatives include extension of states' civil statutes of limitations for child sexual abuse lawsuits, research and analysis of the barriers to public benefits that women encounter, a report on immigrant women's access to reproductive health care, and a legislative scorecard on women's issues.
CONTACT: Ms. Foundation for Women, 12 MetroTech Center, 26th Floor, Brooklyn, NY 11201, (212) 742-2300, e-mail: info@ms.foundation.org. For more information see http://forwomen.org/content/120/en/fellowship
From The Foundation Center's Philanthropy News Digest RFP Bulletin e-mail, 1/11/13icon
Subject(s) health policy research, women’s health

Research Proposals in Areas of Unmet Medical Need
SOURCE: Leukemia & Lymphoma Society
APPLICATION DEADLINE: Letter of Intent: 3/1/13.
$ AVAILABLE: Each grant provide up to $600,000 over three years.
ELIGIBILITY: Applicants (principal investigators) must hold an M.D., Ph.D., or equivalent degree, and work in a nonprofit organization (domestic or foreign), university, college, hospital, or lab. Applications may involve multiple institutions and the applicant should have an independent research or academic position. Applicants need not be United States citizens.
PURPOSE: The Leukemia & Lymphoma Society has issued new Requests for Proposals through its Translational Research Program to support researchers in six critical areas of unmet medical need. The RFPs mark LLS's aggressive and proactive approach to addressing the challenge of improving outcomes for cancer patients with particularly urgent needs.
The LLS Translational Research Program is designed to help accelerate the movement of promising discoveries from lab to clinic. The goal of translational research is to reduce the time between laboratory findings and actual treatment.
The society aims to stimulate more academic research in the following areas: new immunotherapeutics for patients with acute myelogenous leukemia; novel therapeutics for patients with non-cutaneous T-cell malignancies; introduction of novel agents in the treatment of patients with diffuse large B-cell lymphoma and mantle cell lymphoma; therapies for patients with myelodysplastic syndromes who have failed hypomethylating agents; therapies for new targets such as bromodomains, methylation, and other epigenetic approaches for patients with high-risk myeloma; and research that addresses long-term and late effects of blood cancer therapies.
CONTACT: Director of Research Administration, The Leukemia & Lymphoma Society, 1311 Mamaroneck Ave., White Plains, NY 10605, (914) 821-8301, (914) 821-8290, e-mail: researchprograms@lls.org. For more information see http://www.lls.org/#/researchershealthcareprofessionals/academicgrants/translationalresearch/
From The Foundation Center's Philanthropy News Digest RFP Bulletin e-mail, 1/11/13icon
Subject(s) medical research, health professions training, cancer research

Senior Scholar in Aging Award
SOURCE: Ellison Medical Foundation
APPLICATION DEADLINE: Letter of Intent: 3/7/13.
$ AVAILABLE: Awards provide up to $150,000 in direct costs per year, plus full indirect costs for four years. Up to 25 Senior Scholar awards will be made.
ELIGIBILITY: Established investigators employed by 501(c)(3) institutions, colleges, universities, or nonprofit research organizations are eligible to apply.
PURPOSE: The Ellison Medical Foundation Senior Scholar program is designed to help established investigators working at institutions in the United States conduct research in the basic biological and basic biomedical sciences relevant to understanding lifespan development processes and age-related diseases and disabilities.
The award is intended to provide significant support to allow the development of new, creative research programs by investigators who currently may not be conducting aging research or who wish to develop new research programs in aging. The foundation particularly seeks to stimulate new research that has rigorous scientific foundations but is inadequately funded, either because of its perceived novelty, high risk, or because it is from an area where other "traditional" research interests absorb most funding.
Areas of interest include but are not limited to structural biology, molecular genetics, studies with model systems ranging from lower eukaryotes to humans, inquiries testing the relevance of simpler models to human aging, genetic epidemiology of aging, aging in the immune system, host defense molecules in aging systems, mechanisms of free radical-induced cell aging, mechanisms of aging in various differentiated cell populations, gene/environment and gene/gene interactions, integrative physiology, and new approaches to age-modulated disease mechanisms.
CONTACT: Kevin Lee, (301) 829-6410, e-mail: klee@ellisonfoundation.org. For more information see http://www.ellisonfoundation.org/how-to-apply-senior-scholar
From The Foundation Center's Philanthropy News Digest RFP Bulletin e-mail, 1/11/13icon
Subject(s) medical research, health professions training, aged/seniors


Events

Grant Proposal Writing
SPONSOR: Zocklein & Associates
WHEN: February 5-6, 8:30 am to 5 pm.
WHERE: Staybridge Suites Downtown, 123 Hoefgen, (San Antonio, TX).
DESCRIPTION: Zocklein & Associates has been offering grant writing and resource development training to nonprofit organizations, government agencies and schools since January, 1995. To date, more than 70,000 people have been trained in over 3000 workshops and conferences held in 38 states and the District of Columbia.
The purpose of our training is to equip nonprofit organizations, government agencies and schools with the tools to achieve and maintain fiscal stability in order to carry out their mission in service to the community. We teach participants to use grants as a way to launch a program and then secure long-term funding to insure program continuance after the grant money is gone. This long-term funding plan, Circle of Resource Entanglements or C.O.R.E., diversifies resources and reduces grant dependency. The C.O.R.E. can also be used to increase unrestricted funds.
The training includes an overview of new 501c3 nonprofit corporation start-up procedures. This is of particular interest to tax supported agencies or schools which can augment their programs with private contributions made to a “Friends of…”. We estimate that an average of two participants per workshop have formed new nonprofit organizations over the past twelve years.
COST: $375 per person.
CONTACT: Zocklein & Associates, (800) 371-5703.
From Zocklein & Associates fax, 1/17/13icon

Grant Proposal Writing
SPONSOR: Zocklein & Associates
WHEN: March 13-14, 8:30 am to 5 pm.
WHERE: Holiday Inn Express, 4321 Communications Drive, (Dallas, TX).                                                                      
DESCRIPTION: Zocklein & Associates has been offering grant writing and resource development training to nonprofit organizations, government agencies and schools since January, 1995. To date, more than 70,000 people have been trained in over 3000 workshops and conferences held in 38 states and the District of Columbia.
The purpose of our training is to equip nonprofit organizations, government agencies and schools with the tools to achieve and maintain fiscal stability in order to carry out their mission in service to the community. We teach participants to use grants as a way to launch a program and then secure long-term funding to insure program continuance after the grant money is gone. This long-term funding plan, Circle of Resource Entanglements or C.O.R.E., diversifies resources and reduces grant dependency. The C.O.R.E. can also be used to increase unrestricted funds.
The training includes an overview of new 501c3 nonprofit corporation start-up procedures. This is of particular interest to tax supported agencies or schools which can augment their programs with private contributions made to a “Friends of…”. We estimate that an average of two participants per workshop have formed new nonprofit organizations over the past twelve years.
COST: $375 per person.
CONTACT: Zocklein & Associates, (800) 371-5703.
From Zocklein & Associates fax, 1/17/13icon


returnReturn to Alert 

  • Loading...
Last updated June 17, 2014